BPC-157

BPC‑157 – Stable Gastric Pentadecapeptide for Regeneration Research

BPC‑157 (Body Protective Compound‑157) is a synthetic pentadecapeptide originally isolated from a protective protein found in gastric juice, extensively studied in preclinical models for its cytoprotective and pro‑regenerative properties across multiple tissues. Research suggests that BPC‑157 can modulate key pathways involved in angiogenesis, inflammation, and cellular migration, making it a versatile tool for investigating musculoskeletal, gastrointestinal, vascular, and neurologic repair mechanisms.

Key features

• Broad tissue‑healing focus: In animal models, BPC‑157 has been shown to accelerate healing of tendons, ligaments, muscles, bones, skin, and the gastrointestinal mucosa, with improvements in structural, biomechanical, and functional outcomes.

• Angiogenesis and blood‑flow support: Studies indicate BPC‑157 upregulates VEGF signaling and nitric‑oxide–related pathways, enhancing new blood‑vessel formation and microvascular recovery at injury sites.

• Inflammation and cytoprotection: Preclinical data show reductions in COX‑2 expression, myeloperoxidase activity, and pro‑inflammatory cytokines such as IL‑6 and TNF‑α, alongside protection of gut, liver, pancreas, cardiovascular, and nervous tissues in various injury models.

• Mechanistic depth: BPC‑157 has been linked to activation of ERK1/2, FAK–paxillin, and related signaling networks governing cell migration, survival, and tissue remodeling at the tendon, muscle, and vascular interface.

  
  

Research applications

BPC‑157 is utilized in experimental models exploring:

• Musculoskeletal repair, including tendon rupture, ligament tear, muscle crush/transection, and fracture healing, with reported improvements in load to failure, morphology, and functional recovery.

• Gastrointestinal and organ protection in ulcer, colitis, liver, pancreatic, and vascular‑injury models, where it has demonstrated notable mucosal and endothelial stabilization effects.

• Neuroprotection and neuromuscular stability, including models of spinal cord injury, peripheral nerve damage, and modulation of dopamine/serotonin pathways along the gut–brain axis.

  
  

Recommended handling

• For controlled laboratory research use only, by trained professionals.

• Store in a cool, dry environment away from light; follow institutional SOPs for peptide storage, reconstitution, sterile technique, and disposal.

• Investigators should reference current literature when designing dosing, route of administration, and outcome measures appropriate to each model.

  
  

Important disclaimer

All compounds sold by Rocky Peptide Chain, including BPC‑157, are for research use only. They are not intended for human consumption, medical use, diagnostic purposes, or treatment of any disease or condition. No claims are made or implied regarding clinical efficacy, performance enhancement, or therapeutic benefit. Researchers are solely responsible for proper handling, experimental design, and adherence to all applicable regulations.